Prostate cancer survivorship of Australian men living with prostate cancer: Patient support programs in Australia.

IF 1.6 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Australian Journal of General Practice Pub Date : 2024-10-01 DOI:10.31128/AJGP-02-24-7141

Brian Ng Hung Shin, Handoo Rhee, Eric Chung

{"title":"Prostate cancer survivorship of Australian men living with prostate cancer: Patient support programs in Australia.","authors":"Brian Ng Hung Shin, Handoo Rhee, Eric Chung","doi":"10.31128/AJGP-02-24-7141","DOIUrl":null,"url":null,"abstract":"Background: Treatment for prostate cancer (PC) is associated with adverse effects, especially in patients receiving androgen deprivation therapy (ADT). The Australian Government, non-governmental organisations and pharmaceutical companies responsible for marketing ADT have initiated and sponsored various strategic support programs for patients diagnosed with PC.Objective: This professional article provides an overview of available PC patient support programs in Australia to assist general practitioners (GPs) to direct patient referrals and optimise clinical care.Discussion: These PC support programs provide useful assistance on educational materials, decision support, clinical care management and referral to specialised services (eg continence advice, sexual health counselling and psychological support). More concerted efforts and smarter investment in PC survivorship programs are necessary to engage, educate and improve the lives of men living with PC more effectively.","PeriodicalId":54241,"journal":{"name":"Australian Journal of General Practice","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Journal of General Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31128/AJGP-02-24-7141","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Treatment for prostate cancer (PC) is associated with adverse effects, especially in patients receiving androgen deprivation therapy (ADT). The Australian Government, non-governmental organisations and pharmaceutical companies responsible for marketing ADT have initiated and sponsored various strategic support programs for patients diagnosed with PC.

Objective: This professional article provides an overview of available PC patient support programs in Australia to assist general practitioners (GPs) to direct patient referrals and optimise clinical care.

Discussion: These PC support programs provide useful assistance on educational materials, decision support, clinical care management and referral to specialised services (eg continence advice, sexual health counselling and psychological support). More concerted efforts and smarter investment in PC survivorship programs are necessary to engage, educate and improve the lives of men living with PC more effectively.

查看原文本刊更多论文

澳大利亚男性前列腺癌患者的生存状况：澳大利亚的患者支持计划。

背景：前列腺癌（PC）的治疗与不良反应有关，尤其是对接受雄激素剥夺疗法（ADT）的患者。澳大利亚政府、非政府组织和负责销售 ADT 的制药公司发起并赞助了针对确诊为 PC 患者的各种战略支持计划：这篇专业文章概述了澳大利亚现有的 PC 患者支持计划，以帮助全科医生（GPs）指导患者转诊并优化临床护理：这些 PC 支持计划在教育材料、决策支持、临床护理管理和专业服务转介（如尿失禁建议、性健康咨询和心理支持）方面提供了有益的帮助。为了更有效地参与、教育和改善男性 PC 患者的生活，有必要在 PC 幸存者计划方面做出更多共同努力和更明智的投资。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australian Journal of General Practice Medicine-Family Practice

CiteScore

2.80

自引率

4.50%

发文量

284

期刊介绍： The Australian Journal of General Practice (AJGP) aims to provide relevant, evidence-based, clearly articulated information to Australian general practitioners (GPs) to assist them in providing the highest quality patient care, applicable to the varied geographic and social contexts in which GPs work and to all GP roles as clinician, researcher, educator, practice team member and opinion leader. All articles are subject to peer review before they are accepted for publication.